Holding | Rating | % Fund |
---|---|---|
Morgan Stanley | A | 1.3% |
AbbVie | A | 1.2% |
United States Government | AAA | 1.2% |
Smb Private Education Loan Trust 2024-a | BBB | 1.1% |
Bristol-Myers Squibb | A | 1.0% |
Holding | Rating | % Fund |
---|---|---|
Goldman Sachs | A | 1.0% |
Teva | BB | 0.9% |
Amgen | BBB | 0.9% |
JPMorgan Chase | AA | 0.9% |
Freddie Mac - Stacr_20-dna4 | B | 0.8% |
Asset type | % Fund |
---|---|
Other | 1.8% |
Cash & Equivalent | 6.9% |
Corporate Not Rated | 0.0% |
Emerging Markets | 12.6% |
High Yield | 31.6% |
BB | 18.0% |
B | 11.2% |
CCC & below | 2.4% |
Investment Grade Corporates | 31.6% |
Securitized | 15.5% |
Name | % Fund |
---|---|
United States | 73.5% |
United Kingdom | 1.9% |
Mexico | 1.7% |
Brazil | 1.5% |
Canada | 1.2% |
Other | 13.3% |
Cash & equivalents | 6.9% |